Literature DB >> 8121551

"Brain attack": the rationale for treating stroke as a medical emergency.

P J Camarata1, R C Heros, R E Latchaw.   

Abstract

Stroke is the third leading cause of death in the United States, behind only heart disease and cancer. With an estimated three million survivors of stroke in the United States, the cost to society, both directly in health care and indirectly in lost income, is staggering. Despite recent advances in basic and clinical neurosciences, which have the potential to improve the treatment of acute stroke, the general approach to the acute stroke patient remains one of therapeutic nihilism. Most basic science studies show that to be effective, acute intervention to reperfuse ischemic tissue must take place within the first several hours, as is the case with ischemic myocardium. In addition, most neuroprotective agents must also be administered within a short time frame to be effective at salvaging at-risk tissue. Recent studies have suggested that the outcome after intracerebral and subarachnoid hemorrhage is improved with early intervention. However, most stroke patients fail to present to medical attention within this short "window of opportunity." The public's knowledge about stroke is woefully inadequate. However, clinicians who deal with stroke can use the dramatic changes in the treatment of acute myocardial infarction over the last 2 decades as a guide for shaping changes in the management of acute stroke. Comprehensive educational efforts aimed at clinicians and the public at large have dramatically reduced the time from symptom onset to presentation and treatment for acute myocardial infarction, enabling treatment methods such as thrombolysis to be effective. The Decade of the Brain offers a unique opportunity to all concerned with the treatment of the patient with acute stroke to engage in a concerted effort to bring patients with a "brain attack" to specialized neurological attention within the same timeframe that the "heart attack" patient is handled. Such an effort is justified because, although at the present time there are few therapeutic interventions of "proven" value in the treatment of acute stroke, there is more than sufficient suggestive evidence that a number of approaches may be beneficial within the first few hours after the onset of the stroke.

Entities:  

Mesh:

Year:  1994        PMID: 8121551     DOI: 10.1097/00006123-199401000-00021

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  18 in total

1.  Why were the benefits of tPA exaggerated?

Authors:  Griffin Trotter
Journal:  West J Med       Date:  2002-05

2.  Lys-plasminogen as an adjunct to local intra-arterial fibrinolysis for carotid territory stroke: laboratory and clinical findings.

Authors:  H J Freitag; V U Becker; A Thie; V Tilsner; A Philapitsch; H P Schwarz; U Webhof; A Müller; H Zeumer
Journal:  Neuroradiology       Date:  1996-02       Impact factor: 2.804

Review 3.  Cost considerations in the pharmacological prevention and treatment of stroke.

Authors:  A V Alexandrov; L T Smurawska; W Bartle; P Oh
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

4.  Carotid endarterectomy.

Authors:  P Balousek; J H Neal
Journal:  West J Med       Date:  1995-03

Review 5.  Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists.

Authors:  Ramya Kapadia; Jae-Hyuk Yi; Raghu Vemuganti
Journal:  Front Biosci       Date:  2008-01-01

Review 6.  Antithrombotic therapy for patients with stroke symptoms. Guidelines for family physicians.

Authors:  J Brown; M Bernstein
Journal:  Can Fam Physician       Date:  1996-09       Impact factor: 3.275

7.  Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine.

Authors:  G A Zimmerman; M Meistrell; O Bloom; K M Cockroft; M Bianchi; D Risucci; J Broome; P Farmer; A Cerami; H Vlassara
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

8.  Training the brain to survive stroke.

Authors:  Jeff F Dunn; Ying Wu; Zonghang Zhao; Sathya Srinivasan; Sirajedin S Natah
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

9.  Neuropathic pain as a process: reversal of chronification in an animal model.

Authors:  Liliane J Dableh; Kiran Yashpal; James L Henry
Journal:  J Pain Res       Date:  2011-09-29       Impact factor: 3.133

10.  Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes.

Authors:  Lilia Fisk; Natalia N Nalivaeva; John P Boyle; Christopher S Peers; Anthony J Turner
Journal:  Neurochem Res       Date:  2007-05-08       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.